Keyphrases
Neurofibromatosis Type 1 (NF-1)
100%
Neurofibromatosis Type I
93%
Intellectual Disability
64%
Attention Deficit Hyperactivity Disorder
57%
Microcephaly
53%
Thin Corpus Callosum
46%
Migraine
46%
Pseudotumor Cerebri
46%
Cerebrospinal Fluid
46%
Homozygosity Mapping
44%
Seizure
44%
Epilepsy
41%
Israel
40%
Cerebellar Hypoplasia
38%
TAF2
34%
Novel mutation
34%
Brain Magnetic Resonance Imaging
34%
Hypotonia
33%
Electroencephalography
31%
Pediatric
30%
Electroencephalogram
29%
Corpus Callosum
29%
Imaging Findings
27%
Sensory Processing Disorder
27%
Related Disorders
27%
Myoclonic Epilepsy
27%
Consanguineous Family
27%
Prospective Cross-sectional Study
26%
Etiology
25%
Clinical Presentation
23%
Genetic Characterization
23%
Infantile Spasms
23%
Early Infantile
23%
Pediatric Magnetic Resonance Imaging
23%
EXOSC3
23%
Incidental
23%
Central Nervous System
23%
Clinical Characterization
23%
SCN2A mutation
23%
Symporter
23%
SLC25A22
23%
Early Myoclonic Encephalopathy
23%
Half-sibling
23%
Acute Transverse Myelitis
23%
Congenital Myasthenic Syndrome
23%
Congenital Anomalies
23%
Complex Visual Hallucinations
23%
Infant Development
23%
Hyperactivity Disorder
23%
Germline Mosaicism
23%
Medicine and Dentistry
Neurofibromatosis Type I
100%
Magnetic Resonance Imaging
70%
Diseases
67%
Pediatrics
64%
Attention Deficit Disorder
52%
Congenital Malformation
49%
Corpus Callosum
46%
Migraine
46%
Sensory Processing
46%
Autosomal Recessive Inheritance
42%
Headache
42%
Disease
34%
Hypotonia
33%
Epileptic Seizure
32%
Lafora Disease
29%
Cerebrospinal Fluid
27%
Intellectual and Developmental Disabilities
27%
Homozygosity
25%
Cutis Laxa
23%
Methylphenidate
23%
Transverse Myelitis
23%
Patient Referral
23%
Ganglioglioma
23%
Apoplexy
23%
Strengths and Difficulties Questionnaire
23%
White Matter Lesion
23%
Hydrocephalus
23%
Continuous Performance Test
23%
Congenital Myasthenic Syndrome
23%
DeJerine-Sottas Disease
23%
Brain Pseudotumor
23%
Microcephaly
23%
Visual Hallucination
23%
Vertebral Artery Dissection
23%
Glycosylphosphatidylinositol
23%
Brain Imaging
23%
Hypoplasia
23%
Quality of Life
23%
Microgyria
23%
Central Nervous System
23%
Disease Severity
23%
Croup
23%
Infantile Neuronal Ceroid Lipofuscinosis
23%
Dexamethasone
23%
Betamethasone
23%
Language Delay
23%
Selective Mutism
23%
Batten Disease
23%
Social Interaction
23%
Disease Course
19%